Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Undefined

ABSTRACT: SJPedPanel: A pan cancer gene panel for childhood malignancies

PROVIDER: PRJEB64356 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR11728500_1.fastq.gz	Fastqsanger.gz
	ERR11728500_2.fastq.gz	Fastqsanger.gz
	ERR11728372_1.fastq.gz	Fastqsanger.gz
	ERR11728372_2.fastq.gz	Fastqsanger.gz
	ERR11728373_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 50

Similar Datasets

undefined

Project description:Gene panel sequencing male breast cancer

| PRJEB57620 | ENA

Project description:Validation and implementation of a Pan Cancer Next-Generation Sequencing Panel, CANSeqTMKids for molecular profiling of childhood malignancies

| PRJNA930398 | ENA

undefined

Project description:Genome-scale pan-cancer interrogation of lncRNA dependencies using CasRx

| PRJEB60776 | ENA

Immune profiling of lymph nodes drained to cold vs hot triple-negative breast tumors.

Project description:NanoString pan-cancer immune panel was used to quantified the expression of 730 immune genes of 15 tumor-free TDLNs and paired tumors. FFPE slides were used to quantified the gene expression.

2024-07-29 | GSE272455 | GEO

NanoString nCounter Human HCC expression analysis

Project description:Archival tumor tissues from HCC patients recruited in the Ph 3 RESORCE trial were analysed with the pan Cancer immune profiling panel

2019-01-01 | GSE119220 | GEO

Profiling gene expressions of cancer-associated canonical pathways between cold and hot triple-negative breast tumors.

Project description:NanoString nCounter pan-cancer pathway panel was used to quantified the expression of 730 genes related to 13 canncer-assocaited canonical pathways from 15 triple-negative breast tumors. FFPE slides were used to quantified the gene expression.

2024-07-29 | GSE272453 | GEO

Inhibition of glycolysis and mitochondrial respiration promotes radiosensitisation of neuroblastoma and glioma cells

Project description:<h4><strong>BACKGROUND: </strong>Neuroblastoma accounts for 7% of paediatric malignancies but is responsible for 15% of all childhood cancer deaths. Despite rigorous treatment involving chemotherapy, surgery, radiotherapy and immunotherapy, the 5-year overall survival rate of high-risk disease remains < 40%, highlighting the need for improved therapy. Since neuroblastoma cells exhibit aberrant metabolism, we determined whether their sensitivity to radiotherapy could be enhanced by drugs affecting cancer cell metabolism.</h4><h4><strong>METHODS:</strong> Using a panel of neuroblastoma and glioma cells, we determined the radiosensitising effects of inhibitors of glycolysis (2-DG) and mitochondrial function (metformin). Mechanisms underlying radiosensitisation were determined by metabolomic and bioenergetic profiling, flow cytometry and live cell imaging and by evaluating different treatment schedules.</h4><h4><strong>RESULTS:</strong> The radiosensitising effects of 2-DG were greatly enhanced by combination with the antidiabetic biguanide, metformin. Metabolomic analysis and cellular bioenergetic profiling revealed this combination to elicit severe disruption of key glycolytic and mitochondrial metabolites, causing significant reductions in ATP generation and enhancing radiosensitivity. Combination treatment induced G<sub>2</sub>/M arrest that persisted for at least 24 h post-irradiation, promoting apoptotic cell death in a large proportion of cells.</h4><h4><strong>CONCLUSION: </strong>Our findings demonstrate that the radiosensitising effect of 2-DG was significantly enhanced by its combination with metformin. This clearly demonstrates that dual metabolic targeting has potential to improve clinical outcomes in children with high-risk neuroblastoma by overcoming radioresistance.</h4>

2022-11-30 | MTBLS858 | MetaboLights

undefined

Project description:pan-susceptible mycobacterium tuberculosis from Georgia

| PRJEB50582 | ENA

Capturing the dynamic interactions between tumor and immune components of the tumor micro-environment is important for determining efficacy of anti-PD1 treatment [TBL]

Project description:RNA of tumor samples from 14 patients with head and neck squamous cell carcinoma treated anti-PD1 was analyzed on the nCounter system using the Pan cancer IO360 panel

2024-01-09 | GSE233980 | GEO

Capturing the dynamic interactions between tumor and immune components of the tumor micro-environment is important for determining efficacy of anti-PD1 treatment [Post Culture_Metadata]

Project description:RNA extracted from the post 72 hour cultured tumor samples from 31 patients with head and neck squamous cell carcinoma treated Nivolumab and Nivolumab+Ipilimumab was analyzed on the nCounter system using the Pan cancer IO360 panel.

2024-01-09 | GSE234136 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data